Skip to main content

Month: May 2020

THL Credit Senior Loan Fund Announces Shareholder Approval of New Advisory Agreement and Fund Name Change

BOSTON, May 11, 2020 (GLOBE NEWSWIRE) — THL Credit Senior Loan Fund (the “Fund”) (NYSE: TSLF), a registered closed-end investment company, announced today that its shareholders approved a new advisory agreement (the “New Advisory Agreement”) between the Fund and First Eagle Alternative Credit, LLC (formerly known as THL Credit Advisors LLC) (the “Adviser”) at the Fund’s Annual Meeting of Shareholders held on May 8, 2020.  The approval of the New Advisory Agreement follows the transaction between the Adviser and First Eagle Investment Management, LLC (“FEIM”) that was consummated in the first quarter of 2020, whereby the Adviser became a wholly owned subsidiary of FEIM.As a result of shareholder approval of the New Advisory Agreement, the Fund is making a number of related changes, including...

Continue reading

NewAge Reports 9% First Quarter Revenue Growth With Highest Q1 Revenue Performance in Its History

Q1 2020 net revenue was nearly $64 million, an increase of 9% versus prior year, 6% of which was organic growthGross margin reached 65%, a significant increase versus prior quarters in the second half of 2019 as product, channel mix, and product profitability improvedKey markets of China, Japan, and North America saw growth versus the first quarter of 2019.  Online ordering and direct-to-home fulfillment model resonating worldwide DENVER, May 11, 2020 (GLOBE NEWSWIRE) — New Age Beverages Corporation (Nasdaq: NBEV), the Colorado-based healthy products company dedicated to inspiring and educating the planet to “live healthy”, today announced financial results for the first quarter ended March 31, 2020,  reaching its highest level of first quarter net revenue in its history at $63.7 million.Key HighlightsNet revenue was $63.7 million...

Continue reading

Rubicon Organics Receives License to Sell Cannabis from Health Canada

VANCOUVER, British Columbia, May 11, 2020 (GLOBE NEWSWIRE) — Rubicon Organics Inc. (CSE:ROMJ) (OTCQX:ROMJF) (“Rubicon Organics” or the “Company) is pleased to announce that it has received its sales amendment from Health Canada to sell dried and fresh cannabis products for recreational use (the “Sales License”). With the receipt of the Sales License, Rubicon Organics is now able to directly sell its premium organic certified flower to all provincial and territorial distributors.  “Today marks an important milestone for Rubicon Organics on our journey to become Canada’s leading organic cannabis company,” stated Jesse McConnell, CEO. “This Sales License will enable us to launch our full portfolio of super-premium brands, into new provinces such as Alberta and Quebec, whilst extending our offerings in our already supplied provinces,...

Continue reading

No. 12 2020 Share trading in Solar A/S

In accordance with article 19 of Regulation (EU) No 596/2014, Solar is required to report share trading in Solar A/S of members of the Board of Directors, members of the Executive Board and related parties. The information in the below statements is based on reports from the above-mentioned persons to Solar.Yours faithfully,Solar A/SCharlotte Risskov KræftingContact: Director, Stakeholder Relations Charlotte Risskov Kræfting – tel. +45 40 34 29 08.Facts about Solar Solar is a leading European sourcing and services company mainly within electrical, heating and plumbing, ventilation and climate and energy solutions. Our core business centres on product sourcing, value-adding services and optimisation of our customers’ businesses.We facilitate efficiency improvement and provide digital tools that turn our customers into winners. We...

Continue reading

Solar A/S: Nr. 12 2020 Aktiehandel i Solar A/S

I henhold til EU-forordning 596/2014 artikel 19 skal Solar meddele bestyrelsesmedlemmer, direktionen og disses nærtståendes handel med aktier i Solar A/S. Oplysningerne i nedenstående oversigter er baseret på de nævnte personers indberetninger til Solar.Med venlig hilsenSolar A/SCharlotte Risskov KræftingKontaktperson: Director, Stakeholder Relations Charlotte Risskov Kræfting – tlf. +45 40 34 29 08.Fakta om Solar Solar-koncernen er en førende europæisk sourcing- og servicevirksomhed, der leverer løsninger primært inden for el, vvs, ventilation samt klima og energi. Vores kerneforretning centrerer sig om sourcing af produkter, værdiskabende services og optimering af vores kunders forretning.Vi fremmer effektivitetsforbedringer og tilbyder digitale værktøjer, der gør vores kunder til vindere. Vi driver den grønne omstilling og leverer...

Continue reading

RESULT OF SEK CREDIT OPERATION 2020-05-11

May 11, 2020 05:45 ET | Source: Sveriges RiksbankRESULT OF SEK CREDIT OPERATION 2020-05-11  Auction date: 2020-05-11Payment date: 2020-05-11 (at 3 pm)Maturity date: 2020-08-11Term: 92 daysOffered volume: UnlimitedTotal bid amount: SEK 0.0 billionNumber of bids 0Allotment: SEK 0.0 billionInterest rate: Repo rate + 0,20 percentage pointsProfileSveriges RiksbankStockholm, SWEDENMedia FilesFormats available:

Continue reading

Anti-Inflammatory Biologics Market to Reach USD 149.80 Billion by 2027; Ongoing Trials for Anti-Tumour Necrosis Factor (TNF) to Elevate Market Scope, states Fortune Business Insights™

Pune, May 11, 2020 (GLOBE NEWSWIRE) — The global anti-inflammatory biologics market size is expected to reach USD 149.80 billion by 2027, exhibiting a CAGR of 11.0% during the forecast period. The indication of an inflammatory surplus in patients with COVID-19 along with plentiful neutrophils and macrophages will revivify growth prospects for the anti-inflammatory biologics market share during the forecast period. The ongoing trials for anti-tumor necrosis factor (TNF) antibodies in severe cases of autoimmune inflammatory disease such as rheumatoid arthritis, inflammatory bowel disease, or ankylosing spondylitis will aid the speedy expansion of the market during the forecast period, mentioned by Fortune Business Insights, in a report, titled “Anti-Inflammatory Biologics Market Size, Share & Industry Analysis, By Drug Class...

Continue reading

Heimavellir hf.: Framboð til stjórnar Heimavalla hf. á hluthafafundi þann 14. maí 2020

Framboð til stjórnar Heimavalla hf. á hluthafafundi 14. maí 2020.Hluthafafundur Heimavalla hf. verður haldinn þann 14. maí 2020 kl. 15:00 á Hilton Reykjavík Nordica, Suðurlandsbraut 2, 108 Reykjavík.Framboðsfrestur til stjórnar Heimavalla hf. rann þann 9 maí. síðastliðinn.Eftirtaldir aðilar hafa gefið kost á sér í stjórn félagsins:Andreas Søtvedt OulieArve ReglandHelge KrogsbølStjórn hefur metið öll framboð til stjórnar gild, sbr. 63.gr.a laga um hlutafélög nr. 2/1995.Nánari upplýsingar um frambjóðendur er að finna í viðhengi.AttachmentYfirlit yfir stjórnarframboð til birtingar í kauphöll og á heimasíðu Heimavalla 14.maí 2020

Continue reading

ASLAN Pharmaceuticals Reports First Quarter 2020 Financial Results and Provides Corporate Update

SINGAPORE, May 11, 2020 (GLOBE NEWSWIRE) — ASLAN Pharmaceuticals (Nasdaq:ASLN, TPEx:6497), a clinical-stage immunology and oncology focused biopharmaceutical company developing innovative treatments to transform the lives of patients, today reported financial results for the first quarter ended 31 March 2020 and provided an update on its clinical activities.Dr Carl Firth, Chief Executive Officer, ASLAN Pharmaceuticals, said: “The COVID-19 pandemic has brought about unprecedented changes and affected many worldwide. We have been putting strategies in place to mitigate risks to our development programs, including opening sites in different geographies where restrictions are easing. We are also taking steps to ensure that we emerge from this situation stronger and ready to initiate our planned phase 2b study of ASLAN004 for atopic dermatitis...

Continue reading

iQSTEL Announces Subsidiary’s Completed Acquisition of IoT Labs Mexico, an Internet of Things (IoT) Technology Developer, Including the “IoT Smart Gas” Platform

NEW YORK, NY, May 11, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE – iQSTEL Inc. (OTC: IQST) is pleased to announce the 100% acquisition of IoT Labs Mx SAPI (“IoT Labs”) has been completed, an Internet of Things Technology Developer, with its Star Product “IoT Smart Gas Platform”.The IoT Smart Gas Platform consists of in-field equipment, mobile application, and backend software platform, that allows for remote monitoring of LP gas tanks. This is a consumer install-able device that provides real-time gas tank level monitoring and refilling requests via a smartphone app through the company’s gas partners. IoT Labs’ patent-pending device works anywhere there is a radio signal and/or cellular connection, and once connected to the tank, can be left unattended for over 2 years before battery replacement is needed.“IoT Smart Gas units are...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.